Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry

Stephanie M. Jones,Kaylie I. Kirkwood‐Donelson,Georgia M. Alexander,Lalith Perera,Serena M. Dudek,Alan K. Jarmusch
DOI: https://doi.org/10.1002/rcm.9775
IF: 2.586
2024-05-30
Rapid Communications in Mass Spectrometry
Abstract:Rationale Spironolactone is a steroidal drug prescribed for a variety of medical conditions and is extensively metabolized quickly after administration. Measurement of spironolactone and its metabolites remains challenging using mass spectrometry (MS) due to in‐source fragmentation and relatively poor ionization using electrospray ionization. Therefore, improved methods of measurements are needed, particularly in the case of small sample volumes. Methods Girard's reagent P (GP) derivatization of spironolactone was employed to improve response and provide an MS‐based solution to the measurement of spironolactone and its metabolites. We performed ultra‐high‐performance liquid chromatography‐electrospray ionization‐tandem mass spectrometry (UHPLC‐ESI‐MS/MS) and ion mobility spectrometry (IMS)–high‐resolution mass spectrometry (HRMS) to fully characterize the GP derivatization products. Analytes were studied in positive ionization mode, and MS/MS was performed using nonresonance and resonance excitation collision‐induced dissociation. Results We observed the successful GP derivatization of spironolactone and its metabolites using authentic chemical standards. A signal enhancement of 1–2 orders of magnitude was observed for GP‐derivatized versions of spironolactone and its metabolites. Further, GP derivatization eliminated in‐source fragmentation. Finally, we performed GP derivatization and ultra‐high‐performance liquid chromatography–high‐resolution mass spectrometry (UHPLC–HRMS) in a small volume of murine serum (20 μL) from spironolactone‐treated and control animals and observed multiple spironolactone metabolites only in the spironolactone‐treated group. Conclusions GP derivatization was proven to have advantageous mass spectral performance (e.g., limiting in‐source fragmentation, enhancing signals, and eliminating isobaric analytes) for spironolactone and its metabolites. This work and the detailed characterization using ultra‐high‐performance liquid chromatography–high‐resolution tandem mass spectrometry (UHPLC–HRMS/MS) and IMS serve as the foundation for future developments in reaction optimization and/or quantitative assay development.
spectroscopy,chemistry, analytical,biochemical research methods
What problem does this paper attempt to address?